Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis.

HIV cryptococcal meningitis fungal burden raised intracranial pressure visual loss

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 06 11 2020
accepted: 03 02 2021
entrez: 3 5 2021
pubmed: 4 5 2021
medline: 4 5 2021
Statut: epublish

Résumé

Among 472 patients with human immunodeficiency virus-associated cryptococcal meningitis, 16% had severe visual loss at presentation, and 46% of these were 4-week survivors and remained severely impaired. Baseline cerebrospinal fluid opening pressure ≥40 cmH

Identifiants

pubmed: 33937434
doi: 10.1093/ofid/ofab066
pii: ofab066
pmc: PMC8078267
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofab066

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

Clin Infect Dis. 2014 Mar;58(5):736-45
pubmed: 24319084
Clin Infect Dis. 2010 Feb 1;50(3):291-322
pubmed: 20047480
South Afr J HIV Med. 2015 Oct 16;16(1):305
pubmed: 29568574
PLoS One. 2012;7(12):e52895
pubmed: 23285220
Trans R Soc Trop Med Hyg. 1997 Jan-Feb;91(1):44-9
pubmed: 9093627
N Engl J Med. 2018 Mar 15;378(11):1004-1017
pubmed: 29539274
Medicine (Baltimore). 1993 Jul;72(4):207-24
pubmed: 8341139
J Infect. 2015 Jun;70(6):668-75
pubmed: 25444972
AIDS. 2009 Mar 27;23(6):701-6
pubmed: 19279443
Lancet Infect Dis. 2017 Aug;17(8):873-881
pubmed: 28483415

Auteurs

Síle F Molloy (SF)

Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.
Clinical Academic Group in Infection, St George's University Hospital, LondonUnited Kingdom.

Brad Ross (B)

Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.

Cecilia Kanyama (C)

UNC Project, Kamuzu Central Hospital, Lilongwe, Malawi.

Sayoki Mfinanga (S)

National Institute for Medical Research, Muhimbili Centre, Dar es Salaam, Tanzania.
Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Sokoine Lesikari (S)

National Institute for Medical Research, Muhimbili Centre, Dar es Salaam, Tanzania.

Robert S Heyderman (RS)

University College London, London, United Kingdom.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
College of Medicine, Queen Elizabeth Hospital, Blantyre, Malawi.

Newton Kalata (N)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
College of Medicine, Queen Elizabeth Hospital, Blantyre, Malawi.

Jayne Ellis (J)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
College of Medicine, Queen Elizabeth Hospital, Blantyre, Malawi.
The Hospital for Tropical Diseases, University College Hospital, LondonUnited Kingdom.

Charles Kouanfack (C)

Hȏpital Central Yaoundé/Site ANRS Cameroun, Yaoundé, Cameroon.

Duncan Chanda (D)

Institute for Medical Research and Training, University Teaching Hospital, Lusaka, Zambia.

Elvis Temfack (E)

Douala General Hospital, Douala, Cameroon.
National Public Health Laboratory, Yaounde, Cameroon.

Shabir Lakhi (S)

University Teaching Hospital, Lusaka, Zambia.

Anand Moodley (A)

Department of Neurology, University of the Free State, Bloemfontein, South Africa.

Adrienne K Chan (AK)

Dignitas International, Zomba Central Hospital, Zomba, Malawi.
Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

Joep J van Oosterhout (JJ)

Partners in Hope, LilongweMalawi.
David Geffen School of Medicine, University of California, Los Angeles, USA.

Yacouba Mapoure (Y)

Douala General Hospital, Douala, Cameroon.

Peter Mwaba (P)

Department of Internal Medicine and Directorate of Research and Post Graduate Studies, Lusaka Apex Medical University, Lusaka, Zambia.

David G Lalloo (DG)

Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Duolao Wang (D)

Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Olivier Lortholary (O)

Institut Pasteur, Molecular Mycology Unit, Centre National de la Recherche Scientifique, Paris, France.
Paris Descartes University, Necker Pasteur Center for Infectious Diseases and Tropical Medicine, Institut Imagine, Assistance Publique - Hôpitaux de Paris, Paris, France.

Shabbar Jaffar (S)

Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Mina C Hosseinipour (MC)

UNC Project, Kamuzu Central Hospital, Lilongwe, Malawi.
University of North Carolina, Chapel Hill, North Carolina, USA.

Angela Loyse (A)

Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.
Clinical Academic Group in Infection, St George's University Hospital, LondonUnited Kingdom.

Thomas S Harrison (TS)

Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.
Clinical Academic Group in Infection, St George's University Hospital, LondonUnited Kingdom.

Tihana Bicanic (T)

Centre for Global Health, Institute of Infection and Immunity, St George's University of London, London, United Kingdom.
Clinical Academic Group in Infection, St George's University Hospital, LondonUnited Kingdom.

Classifications MeSH